Researchers from Chung-Ang University in South Korea have developed a non-invasive biosensor to detect SDMA levels in urine, which serves as a more reliable indicator of kidney function compared to traditional creatinine tests. SDMA, a byproduct of protein breakdown, accumulates in the bloodstream when kidney function is impaired. This new testing method is easier to use, more sensitive, and does not require advanced equipment, making it suitable for various healthcare settings. The biosensor could facilitate earlier diagnosis and improved treatment outcomes for kidney disease patients worldwide.
Researchers from Chung-Ang University in South Korea have developed a non-invasive biosensor to detect SDMA levels in urine, which serves as a more reliable indicator of kidney function compared to traditional creatinine tests. SDMA, a byproduct of protein breakdown, accumulates in the bloodstream when kidney function is impaired. This new testing method is easier to use, more sensitive, and does not require advanced equipment, making it suitable for various healthcare settings. The biosensor could facilitate earlier diagnosis and improved treatment outcomes for kidney disease patients worldwide.
•The biosensor detects SDMA levels in urine, indicating kidney function.
•SDMA is a byproduct of protein breakdown and accumulates in the bloodstream.
•This method is more reliable than traditional creatinine tests.
•The biosensor is easy to use and does not require advanced equipment.
•It can facilitate earlier diagnosis and improved treatment outcomes.
•The technology may be adapted for detecting other health biomarkers.